Amer Sports Inc (AS) Stock Price Today
Abeona Therapeutics' price target cut to $15 after Q2 revenue miss and operational issues with Zevaskyn therapy.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio advances DNA medicine pipeline with FDA review of INO-3107 and $18.3M funding secured
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Life360 director Morin Brit sells 15,582 shares for $1 million
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera's stock jumps after successful menopause drug trial and CFO insider buying.
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
Airbus leads aerospace market with strong orders despite production challenges
Airbus is outperforming Boeing in commercial aircraft orders, securing 821 net orders in H1 2026 compared to Boeing's 408. Morgan Stanley maintains an "Overweight" rating on Airbus, raising its price target to €255, reflecting confidence in the compa...
Target's stock may face a pullback despite strong Q2 earnings forecast and 57% YTD surge.
Target is expected to report second-quarter earnings of $2.25 per share, a 9.8% increase from last year, with revenues projected at $26.06 billion, up 3.4%. Despite these positive forecasts, the stock has surged 57% year-to-date, leading an analyst t...
Mortgage REIT ETF MORT offers high yield but with moderate risk due to volatile payouts and rate pressures.
The VanEck Mortgage REIT Income ETF (MORT) trades near $10.12 with a trailing yield around 14.7%, reflecting distributions from 27 mortgage REITs. Despite Federal Reserve rate cuts easing funding costs, MORT's payouts remain volatile, influenced by u...
Better.com interim CEO vacations amid founder-led shareholder revolt to oust him and board members
Better.com’s interim CEO Daniel Lewis took a vacation to the South of France during his first full week on the job, even as founder Vishal Garg organized a shareholder revolt controlling 52% of voting shares to remove Lewis and five board members. Ga...
Global X SuperDividend U.S. ETF offers 7% yield but with moderate risk due to volatile, cyclical holdings.
The Global X SuperDividend U.S. ETF delivers a 7% yield by investing in 50 high-yield U.S. stocks, mainly in cyclical and leveraged sectors like shipping and mall REITs. While it appeals to retirees seeking monthly income, the fund's payouts are vola...
Allstate invests in quantum computing to enhance insurance risk pricing ahead of tech arrival.
Insurance company Allstate is proactively investing in quantum computing, expanding its team to explore how the technology can improve risk-based pricing for policies. CEO Tom Wilson acknowledges uncertainty about when quantum computing will fully de...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.